ReviewAdvances in biochemical engineering/biotechnology2025
The Amoeba Dictyostelium discoideum as Novel Production Host for Complex Substances.
Review in Advances in biochemical engineering/biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this chapter, we discuss the necessity of novel chassis organisms for the production of natural products to steer away from petrochemical approaches and the usage of common model organisms. We present the social amoeba Dictyostelium discoideum as a novel host for the production of complex organic substances and exploration of cryptic biosynthetic routes of secondary metabolites. We shed light on the genetic repertoire of the amoeba in terms of natural product biosyntheses and give an overview of growth characteristics, genetic engineering tools, and cultivation methodologies from shake flasks to stirred-tank bioreactors. Finally, an outlook is made on the perspective of D. discoideum as the chassis for biotechnological production and discovery of novel active substances.
Indexed as
Identifiers
40128388What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.